Total: $929.541M

Company
(Symbol)#

Type Of
Financing

Number Of Shares, Units Or Warrants (M)

Amount
Raised
(M)

Investors; Placement
Agents; Details (Date)@


Alkermes Inc.
(ALKS)

Private
placement of
convertible
subordinated
notes

N/A

$100

Alkermes priced $100M worth of the
notes, due in 2023 (8/19)

AtheroGenics
Inc.
(AGIX)

Private
placement of
convertible
notes

N/A

$100

AtheroGenics raised $100M through a
convertible notes sale (8/14)

Australian
Cancer
Technology
Pty Ltd.
(Australia;
ASX:ACU)

Private
placement of
common stock

N/A

A$2.4
(US$1.6)

Australian Cancer Technology raised
US$1.6M (8/14)

Bio-Rad
Laboratories
Inc.
(AMEX:BIO)

Private
placement of
senior
subordinated notes

N/A

$225

Bio-Rad agreed to sell $225M worth of
7.5% senior subordinated notes due 2013 (8/7)

BioSante Pharmaceuticals Inc. (OTC BB:BISP)

Private placement of common stock

4.8S

$10.3

BioSante raised $10.3M in the placement led by SDS Merchant Fund; other investors were Perceptive Life Sciences Fund, SCO Capital Partners LLC, Quogue Capital LLC, Crestview Capital and Orion Biomedical Funds; four BioSante directors also participated (8/6)

Cepheid Inc.
(CPHD)

Private
placement of
common stock

2.8S

$10

Cepheid raised about $10M after selling about 2.8M common shares to an unnamed institutional investor; UBS Securities LLC acted as the offering's financial adviser (8/14)

Ciphergen
Biosystems
Inc.
(CIPH)

Private
placement of
convertible
notes

N/A

$30

Ciphergen raised $30M in a convertible notes offering (8/19)

Cortex
Pharmaceuticals
Inc. (AMEX:COR)

Private placement of common stock and warrants

3.3S and
W for 3.3S

$5

Cortex raised $5M in a private placement with institutional investors; Rodman & Renshaw Inc. served as placement agent for the transaction (8/22)

Curis
Inc.
(CRIS)

Private placement of common stock and warrants

3.6S and W for 1.1S

$10.9

Curis raised about $10.9M through the financing; Stephens Inc. was the transaction's placement agent (8/11)

EpiTan Ltd. (Australia; ASX:EPT)

Private placement of common stock

14.5S

A$7.4(
US$4.8)

EpiTan raised US$4.8M through a placement of 14.5M shares (8/25)

Genelabs Technologies Inc. (GNLB)

Private placement of common stock

1.7S

$2.7

Genelabs raised $2.7M by placing 1.7M shares with one institutional investor; SG Cowen acted as placement agent (8/4)

Genetic Technologies (Australia; ASX:GTG)

Private placement of common stock

13.3S

A$10 (US$6.5)

Genetic Technologies raised US$6.5M through a placement of about 13.3M shares; the placement was managed by Emerging Growth Capital (8/25)

GlycoGenesys Inc. (GLGS)

Private placement of common stock and warrants

7.5S and
W for 2.2S

$4

GlycoGenesys raised about $4M in proceeds from institutional and accredited investors (8/22)

Invitrogen Corp. (IVGN)

Private placement of convertible notes

N/A

$25

Invitrogen raised an additional $25M as part of its $325M convertible notes offering announced in July (8/14)

Labopharm Inc. (Canada; TSE:DDS)

Private placement of common stock

0.2348

C$1.15 (US$0.827)

Labopharm raised another US$827,000 after issuing 234,800 common shares at C$4.90 apiece in an overallotment option exercised by underwriters from its previously reported bought-deal financing conducted in June (8/18)

LifeCell Corp.
(LIFC)

Private placement of common stock

3.3S

$14

LifeCell raised $14M placing about 3.3M shares at $4.25 each; Wells Fargo Securities LLC and Roth Capital Partners LLC were the transaction's placement agents (8/11)

Magistral Biotech
Inc.
(Canada; VSE:MBS)

Private placement of units

U for 3.6S and 0.36W

C$0.724 (US$0.514)

Magistral raised US$514,000 after issuing about 3.6M units composed of about 3.6M common shares and about 360,000 warrants to acquire about 360,000 common shares (8/21)

Nymox Pharmaceutical
Corp.
(NYMX)

Private placement of common stock

N/A

$12

Nymox raised $12M through the sale of common stock to institutional investors (8/27)

Oncolytics Biotech Inc. (Canada; ONCY; TSE:ONC)

Private placement of common stock and warrants

1.36S and 0.682W

C$4.1 (US$2.9)

Oncolytics raised US$2.9M through a private sale of about 1.36M shares and 682,000 common share purchase warrants to a group of European and Canadian investors (8/18)

Penwest Pharmaceuticals Co. (PPCO)

Private placement of common stock

2.5S

$52.7

Penwest raised $52.7M, selling a total of 2.5M shares over two days (8/4)

Prima Biomed Ltd. (Australia; ASX:PRR)

Private placement of common stock

11.6S

A$4.3 (US$2.8)

Prima Biomed raised about US$2.8M through the sale of about 11.6M common shares to investment clients of Peregrine Corp. Ltd. (8/8)

QLT Inc. (QLTI)

Private placement of convertible senior notes

N/A

$172.5

QLT raised $172.5M in the private offering (8/11)

Serologicals
Corp.
(SERO)

Private placement of convertible senior subordinated debentures

N/A

$130

Serologicals priced the offering of $130M aggregate principal amount of its 4.75% convertible senior subordinated debentures due 2033 (8/15)

SIGA Technologies Inc. (SIGA)

Private placement of common stock and warrants

0.694S and
W for 0.347S

$1

SIGA raised $1M from MacAndrews & Forbes Holdings Inc., which received about 694,444 shares and warrants to purchase an additional 347,222 shares (8/14)

Tepnel Life Sciences plc (UK; LSE:TED)

Private placement of common stock

9.7S

£1.5 (US$2.4)

Tepnel raised US$2.4M in a placement with existing and new investors (8/13**)

Transgenomic Inc. (TBIO)

Private placement of common stock

N/A

$4.5

Transgenomic raised $4.5M in a financing with two of its largest investors; Fahnestock & Co. Inc. served as placement agent (8/28)


Notes:

This chart does not include real estate or manufacturing plant financings.

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

** Denotes the date the item ran in BioWorld International.

N/A = Not available, applicable or reported.

AMEX = American Stock Exchange; ASX = Australian Stock Exchange; LSE = London Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE = Toronto Stock Exchange; VSE = Vancouver Stock Exchange.

No Comments